Skip to main content

Advertisement

SpringerLink
Log in

Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gydesen S, Brown JM, Brun A et al (2002) Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology 59:1585–1594

    CAS  PubMed  Google Scholar 

  2. Holm IE, Englund E, Mackenzie IRA, Johannsen P, Isaacs A (2007) A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3 (FTD-3). J Neuropathol Exp Neurol 66:884–891

    Article  PubMed  Google Scholar 

  3. Kwiatkowski TJ, Bosco DA, LeClerc AL et al (2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323:1205–1208

    Article  CAS  PubMed  Google Scholar 

  4. Mackenzie IRA, Foti D, Woulfe J, Hurwitz TA (2008) Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. Brain 131:1282–1293

    Article  PubMed  Google Scholar 

  5. Mackenzie IR, Neumann M, Bigio EH et al (2009) Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 117:15–18

    Article  PubMed  Google Scholar 

  6. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IRA (2009) Frontotemporal lobar degeneration with FUS pathology. Brain Aug. 11 (Epub ahead of print)

  7. Neumann M, Roeber S, Kretzschmar HA, Rademakers R, Baker M, Mackenzie IRA (2009) Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol (Epub ahead of print)

  8. Roeber S, Mackenzie IR, Kretzschmar HA, Neumann M (2008) TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD. Acta Neuropathol 116:147–157

    Article  CAS  PubMed  Google Scholar 

  9. Skibinski G, Parkinson NJ, Brown JM et al (2005) Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 37:806–808

    Article  CAS  PubMed  Google Scholar 

  10. Urwin H, Ghazi-Noori S, Collinge J, Isaacs A (2009) The role of CHMP2B in frontotemporal dementia. Biochem Soc Trans 37:208–212

    Article  CAS  PubMed  Google Scholar 

  11. Vance C, Rogelj B, Hortobagyi T et al (2009) Mutations in FUS, an RNA processing protein, cause familial amyotropic lateral sclerosis type 6. Science 323:1208–1211

    Article  CAS  PubMed  Google Scholar 

  12. van der Zee J, Urwin H, Engelborghs S et al (2008) CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet 17:313–322

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Experimental Neuropathology, Danish Neuroscience Center, Aarhus University Hospital, Aarhus, Denmark

    Ida Elisabeth Holm

  2. MRC Prion Unit, UCL Institute of Neurology, London, WC1N 3BG, UK

    Adrian M. Isaacs

  3. Department of Pathology, University of British Columbia, Vancouver, BC, Canada

    Ian R. A. Mackenzie

  4. Department of Pathology, Randers Hospital, Skovlyvej 1, 8900, Randers, Denmark

    Ida Elisabeth Holm

Authors
  1. Ida Elisabeth Holm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adrian M. Isaacs
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ian R. A. Mackenzie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ida Elisabeth Holm.

Additional information

On behalf of the FReJA Consortium.

Appendix

Appendix

The FReJA (Frontotemporal dementia Research in Jutland Association) Consortium:

Anders Gade, Tove Thusgaard, Peter Johannsen, Jørgen Nielsen: Memory Disorders Research Group, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.

Susanne Gydesen: Psychiatric Centre Ballerup, Copenhagen University Hospital, Ballerup, Denmark. Elisabet Englund: Department of Pathology, University Hospital, Lund, Sweden.

Jeremy M. Brown: Department of Neurology, Addenbrooke’s Hospital, Cambridge, UK.

John Collinge: MRC Prion Unit, Department of Neurodegenerative Diseases, UCL, Institute of Neurology, London, UK.

Martin Rossor and Elizabeth M. C. Fisher: Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Holm, I.E., Isaacs, A.M. & Mackenzie, I.R.A. Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. Acta Neuropathol 118, 719–720 (2009). https://doi.org/10.1007/s00401-009-0593-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-009-0593-1

Keywords

Search

Navigation